INFLUENCE OF MAO-INHIBITORS, NEUROLEPTICS, MORPHINE, MESCALINE, DIVASCAN, ACONITINE, AND PYROGENES ON PROSTAGLANDIN-BIOSYNTHESIS

被引:16
作者
BEKEMEIER, H [1 ]
GIESSLER, AJ [1 ]
VOGEL, E [1 ]
机构
[1] MARTIN LUTHER UNIV,DEPT PHARMACOL,PHARM SECT,DDR-402 HALLE,GER DEM REP
来源
PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1977年 / 9卷 / 06期
关键词
D O I
10.1016/S0031-6989(77)80087-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:587 / 598
页数:12
相关论文
共 49 条
[1]  
ALFINSLATER RB, 1971, PROGR BIOCHEM PHARMA, V6, P214
[2]  
BEKEMEIER H, 1975, MEDICAMENTUM, V16, P162
[3]  
BEKEMEIER H, 1974, 2ND C HUNG PHARM SOC, P183
[4]  
BEKEMEIER H, IN PRESS
[5]  
BEKEMEIER H, 1976, MEDICAMENTUM, V17, P138
[6]  
BHATTACH.P, 1973, PHARMACOLOGIST, V15, P209
[7]   INHIBITION OF PROSTAGLANDIN-E2 BIOSYNTHESIS BY DELTA1-TETRAHYDROCANNABINOL [J].
BURSTEIN, S ;
RAZ, A .
PROSTAGLANDINS, 1972, 2 (05) :369-&
[8]  
BURSTEIN S, 1973, BIOCHEM PHARMACOL, V22, P2905
[9]  
BUTT AA, 1974, GUT, V15, P344
[10]  
CARTER GW, 1974, FED PROC, V33, P557